Poland raids major erectile dysfunction drug counterfeiter

Police in Poland have come down hard on a ring they say had perhaps the world’s largest counterfeit Viagra operation.

Authorities there have arrested 14 people and seized equipment and pills from a house near Bydgoszcz. They grabbed 100,000 fake pills for erectile dysfunction and 430,000 vials of steroids that had an estimated value of $4.4 million (€3.95 million), according to Radio Poland citing the AFP news service.

Police said the operation had sold millions of euros worth of the counterfeit drugs over the internet, sometimes labeling them as branded erectile dysfunction drugs and sometimes using their own brands.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

"It was the world's largest factory making anti-impotence drugs according to representatives of four companies whose products were counterfeited," police spokeswoman Agnieszka Hamelusz told AFP.

The counterfeiters had gotten their APIs from China through Greece, Britain and Romania. Police said the manufacturing operations were in hidden rooms that could only be accessed through secret passageways.  

Erectile dysfunction drugs are perhaps the most counterfeited in the world. Earlier this year, U.S. authorities charged a Pakistani man, Junaid Qadir, who they had been seeking for four years for importing into the U.S. counterfeit Viagra and other fakes. Qadir had been indicted by a federal grand jury back in 2012 but was at bay until last year when he was arrested in Germany and held until he was extradited to U.S.

- read the Radio Poland story

Related Articles:
Pakistani man charged with bringing counterfeit drugs into U.S.
FDA finds more counterfeit Cialis, warns consumers

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.